| Kurt Adam Holifield, FNP-C | |
|
6320 W Union Hills Dr Ste 140, Glendale, AZ 85308-7172 | |
| (480) 347-0844 | |
| (480) 347-0885 |
| Full Name | Kurt Adam Holifield |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 6320 W Union Hills Dr Ste 140, Glendale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033819461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 288493 (Arizona) | Primary |
| Entity Name | Vitality Foot And Ankle Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538798004 PECOS PAC ID: 9739501958 Enrollment ID: O20200617000377 |
News Archive
Negative attitudes to ageing affect both physical and cognitive health in later years, new research reveals. The study from the Irish Longitudinal Study on Ageing, at Trinity College Dublin, further reveals that participants with positive attitudes towards ageing had improved cognitive ability.
Syneron Medical Ltd., the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.
Bibby Scientific Ltd, a leading manufacturer of laboratory equipment, announced today that it will be exhibiting some of its newest technologies and offering an exclusive 10% discount to visitors to their stand, G5, at Lab Innovations 2016.
A new study in Biological Psychiatry reports that smoking-related deficits in brain dopamine, a chemical implicated in reward and addiction, return to normal three months after quitting.
Kareus Therapeutics SA, the private biotechnology company focused on the development of novel therapeutics for the unmet treatment of age-related and chronic diseases, today announces the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046, a first-in-class disease modifying new chemical entity discovered for the treatment of Alzheimer's disease using Kareus' proprietary bioenergetics and KARLECT platforms.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kurt Adam Holifield, FNP-C 6320 W Union Hills Dr Ste 140, Glendale, AZ 85308-7172 Ph: (480) 347-0844 | Kurt Adam Holifield, FNP-C 6320 W Union Hills Dr Ste 140, Glendale, AZ 85308-7172 Ph: (480) 347-0844 |
News Archive
Negative attitudes to ageing affect both physical and cognitive health in later years, new research reveals. The study from the Irish Longitudinal Study on Ageing, at Trinity College Dublin, further reveals that participants with positive attitudes towards ageing had improved cognitive ability.
Syneron Medical Ltd., the leading global aesthetic device company announced today, jointly with EndyMed Medical Ltd. and Eclipse Aesthetics, that Syneron has dismissed its United States patent infringement lawsuit against EndyMed and Eclipse Aesthetics relating to EndyMed's Fractional Skin Resurfacing Products.
Bibby Scientific Ltd, a leading manufacturer of laboratory equipment, announced today that it will be exhibiting some of its newest technologies and offering an exclusive 10% discount to visitors to their stand, G5, at Lab Innovations 2016.
A new study in Biological Psychiatry reports that smoking-related deficits in brain dopamine, a chemical implicated in reward and addiction, return to normal three months after quitting.
Kareus Therapeutics SA, the private biotechnology company focused on the development of novel therapeutics for the unmet treatment of age-related and chronic diseases, today announces the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046, a first-in-class disease modifying new chemical entity discovered for the treatment of Alzheimer's disease using Kareus' proprietary bioenergetics and KARLECT platforms.
› Verified 3 days ago
Mrs. Melanie Ann Nugent, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5310 W Thunderbird Rd Ste 301, Glendale, AZ 85306 Phone: 602-865-4442 Fax: 602-865-4507 | |
Kaitlin Spivey, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7701 W Aspera Blvd, Glendale, AZ 85308 Phone: 623-248-2100 | |
Ruth E Sanders, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5041 N 86th Dr, Glendale, AZ 85305 Phone: 866-389-2727 Fax: 612-659-7101 | |
Kelly Lynn Rauch, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7330 N 99th Ave Ste 325, Glendale, AZ 85307 Phone: 623-882-1292 Fax: 623-882-8184 | |
Joyce Kim, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6151-6153 W Olive Ave, Glendale, AZ 85302 Phone: 602-773-5546 | |
Anthony James Shaw, AGACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7190 W Fleetwood Ln, Glendale, AZ 85303 Phone: 602-568-8381 | |
Victoria Bowers, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6808 N Dysart Rd Ste 136, Glendale, AZ 85307 Phone: 623-215-2525 Fax: 623-215-4555 |